← Leaderboards
Rosemary Rochford
University Of Michigan At Ann Arbor
$6,564,789
Attributed
$7,582,192
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,582,192 · 7
By mechanism
R01$6,695,475 · 4
R21$772,625 · 2
R03$114,092 · 1
Top collaborators
- Newton Robert3 shared
- Roberta Pelanda2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- David Clifford Flood$1,508,243
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionBaseChildS LymphomaB-LymphocytesViral Load ResultMalariaEtiologyAfricaKenyaLifeViralPhenotypeAfrican Burkitt&AposTransmission ProcessChildhoodMalignant NeoplasmsEnrollmentCohortMalignant Childhood NeoplasmBurkitt LymphomaEpstein-Barr Virus InfectionsHuman Herpesvirus 4
Grant awards (24)
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma$645,327
R01 · FY2022 · AI · contact PI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma$645,327
R01 · FY2021 · AI · contact PI
Environmental determinants of KSHV transmission in rural Uganda$493,570
R01 · FY2021 · CA · contact PI
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma$673,734
R01 · FY2020 · AI · contact PI
Environmental determinants of KSHV transmission in rural Uganda$624,386
R01 · FY2020 · CA · contact PI
Environmental determinants of KSHV transmission in rural Uganda$489,225
R01 · FY2019 · CA · contact PI
Developing a new model for EBV-mediated T cell diseases$233,250
R21 · FY2017 · AI
Developing a new model for EBV-mediated T cell diseases$194,375
R21 · FY2016 · AI
Effects of Malaria on EBV Persistence in Children$306,448
R01 · FY2014 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$296,971
R01 · FY2013 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$284,656
R01 · FY2012 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$284,657
R01 · FY2011 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$311,666
R01 · FY2010 · CA · contact PI
Micronutrient Malnutrition and EBV Persistence in Children$36,030
R03 · FY2010 · TW · contact PI
Effects of Malaria on EBV Persistence in Children$269,426
R01 · FY2009 · CA · contact PI
Micronutrient Malnutrition and EBV Persistence in Children$39,031
R03 · FY2009 · TW · contact PI
Effects of Malaria on EBV Persistence in Children$261,947
R01 · FY2008 · CA · contact PI
Antiangiogenic Therapy for AIDS-Associated Lymphomas$157,000
R21 · FY2008 · CA · contact PI
Micronutrient Malnutrition and EBV Persistence in Children$39,031
R03 · FY2008 · TW · contact PI
Effects of Malaria on EBV Persistence in Children$259,730
R01 · FY2007 · CA · contact PI
Antiangiogenic Therapy for AIDS-Associated Lymphomas$188,000
R21 · FY2007 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$293,261
R01 · FY2006 · CA · contact PI
Effects of Malaria on EBV Persistence in Children$324,154
R01 · FY2005 · CA
PATHOGENESIS OF EBV ASSOCIATED AIDS LYMPHOMAS$230,990
R01 · FY2000 · CA